Colleen Floreck, Paragon Communications +1 410 975 8708 [email protected]
... expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics - Paragon Bioservices, Inc.
Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare, positioning Catalent for accelerated long-term growth
Image for Chris Holmes' LinkedIn activity called News Announcement - Catalent Pharma Solutions has acquired
University of Maryland BioPark-based Paragon Bioservices will be acquired by contract drug manufacturer Catalent in a $1.2 billion deal, the companies said ...
Biotechnology firm Paragon Bioservices unveiled its new 150,000-square-foot commercial manufacturing facility in
Catalent jumps into 'transformative' gene therapy space with $1.2bn Paragon buy - BioProcess InternationalBioProcess International
Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion – Global Banking & Finance Review
... part of the Paragon success story. Reach out to our Talent Acquisition team at [email protected] to schedule a meeting on June 4 or 5.
N.J.-based Everest Technologies, Philly-based Wolfinger Forensics announce merger Catalent to acquire Paragon Bioservices for $1.2B
To learn more about this exciting combination, visit us at BIO International June 3-6 in Philadelphia, PA. Ask about our “reaching new heights together” ...
Paragon Bioservices Celebrates Grand Opening of its World-Class Gene Therapy Biomanufacturing Facility
Be a part of our success story - check out more than 80 current openings at Paragon by visiting http://tinyurl.com/paragoncareers .pic.twitter.com/ ...
Paragon Bioservices is a leading viral vector development and manufacturing partner for gene therapies. 1Q2019 Life Science Growth Announcements
Image for Carsten Henriksen's LinkedIn activity called Breaking News: Catalent Pharma Solutions to acquire gene
Catalent to Acquire Gene Therapy Leader, Paragon Bioservices, Inc. - Duration: 2 minutes, 34 seconds.
4 N.J. companies rank on DiversityInc's Top 50 for Diversity list Catalent to acquire Paragon Bioservices ...
Solbright, M2M Spectrum merge to create Iota Communications Inc. Catalent to acquire Paragon Bioservices ...
Manufacturing will be a major future differentiator between gene therapy companies, according to one expert.
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion | Markets Insider
Catalent shares the passion to unlock the potential of your product, offering comprehensive solutions and superior technologies for oral, biologic, ...
Catalent to acquire Paragon Bioservices for $1.2B GoFundMe scandal with homeless vet hurts wide range of people, organizations
Catalent's Paragon plans second plant to support Sarepta pipeline - BioProcess InternationalBioProcess International
Vantage announces sale of Gateway Plaza in W. Deptford. PSEG acquires 6th N.C. solar farm · Catalent to acquire Paragon Bioservices ...
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion | Nachricht | finanzen.net